ResearcherYonsei UniversityActive in the last 2 years

Su Hyeong Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4807-4039; OpenAlex author ID A5064900347. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 2 papers

Papers 2

Port-site metastasis after laparoscopic radical pancreatosplenectomy in left-sided pancreatic cancer. Co-author DOI 10.14701/ahbps.23-092 ↗
Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma-Cohort Study. Co-author DOI 10.3390/cancers16101844 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chang Moo Kang · 2 shared papers, 2024 · strength 0.62
- Paper Port-site metastasis after laparoscopic radical pancreatosplenectomy in left-sided pancreatic cancer. DOI 10.14701/ahbps.23-092 ↗
- Paper Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adeno… DOI 10.3390/cancers16101844 ↗
Seung Soo Hong · 1 shared paper, 2024 · strength 0.26
- Paper Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adeno… DOI 10.3390/cancers16101844 ↗
Ho Kyoung Hwang · 1 shared paper, 2024 · strength 0.26
- Paper Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adeno… DOI 10.3390/cancers16101844 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.